Emerging evidence suggests that gastrointestinal (GI) microbiota dysbiosis is associated
with chronic kidney disease (CKD) and metabolite concentrations. The purpose of this …

There is increasing interest in the therapeutic potential of manipulating the gut microbiome
of patients with chronic kidney disease (CKD). This is because there is a substantial …

It is increasingly recognized that the gut microbiota plays a role in the progression of chronic
diseases and that diet may confer health benefits by altering the gut microbiota composition …

Chronic kidney disease (CKD) is a worldwide public health issue and has ultimately
progressed to an end-stage renal disease that requires life-long dialysis or renal …

Background: A bidirectional kidney–gut axis was described in patients with chronic kidney
disease (CKD). On the one hand, gut dysbiosis could promote CKD progression, but on the …

Gut microbiota imbalance is common in patients with chronic kidney disease (CKD) and
associates with factors such as increased circulating levels of gut-derived uremic toxins …

Chronic kidney diseases (CKDs) are a global health problem. Besides diverse leading
reasons in initiation and progression of CKDs, it is evident that they might largely originate …

Background Emerging evidence demonstrates that gut dysbiosis is implicated in the
pathogenesis of chronic kidney disease (CKD) with underlying mechanisms involving …

Chronic kidney disease (CKD) represents a growing public health problem associated with
loss of kidney function and cardiovascular disease (CVD), the main leading cause of …

Objectives: Emerging evidence suggests that gut microbiota dysbiosis plays a critical role in
chronic kidney disease (CKD). However, the relationship between altered gut microbiome …